COMP <GO>
KMTS vs NVCR // EV/EBITDA & P/E VALUATION
Kestra Medical Technologies Ltd. (NASDAQ) VS. NovoCure Limited (NASDAQ) • 15-METRIC TALLY: KMTS 4
— NVCR 6
■ METRIC PARITY
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
valuation
—
LAST: $13.11 (-7.48%) • MKT CAP: $1.53B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KMTS VS. NVCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KMTS | NVCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.40% | 74.50% | -23.10 | NVCR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -27.50% | -7.50 | NVCR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.40% | -4.96% | -1.44 | NVCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -23.50% | -36.50 | NVCR | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -20.80% | -39.20 | NVCR | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | 8.30% | +50.70 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.65 | 0.54 | +9.11 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | NVCR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.5 | 34.0 | +23.49 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $1.53B | $296.6M | KMTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KMTS REV | NVCR REV | KMTS GROSS % | NVCR GROSS % | KMTS FCF | NVCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $95.1M | $655.4M | 51.4% | 74.5% | -$116.6M | -$75.7M |
| FY 2024 | $59.8M | $605.2M | 40.5% | 77.3% | -$100.5M | -$69.2M |
| FY 2023 | $27.8M | $509.3M | — | — | -$72.2M | -$73.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KMTS // BETA —
NVCR // BETA —